These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11294681)
1. Timing of human immunodeficiency virus type 1 and human herpesvirus 8 infections and length of the Kaposi's sarcoma-free period in coinfected persons. Renwick N; Weverling GJ; Schulz T; Goudsmit J J Infect Dis; 2001 May; 183(9):1427. PubMed ID: 11294681 [No Abstract] [Full Text] [Related]
2. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma. Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836 [TBL] [Abstract][Full Text] [Related]
3. Effect of order of infection with human immunodeficiency virus and human herpesvirus 8 on the incidence of Kaposi's sarcoma. Cannon MJ; Pellett PE J Infect Dis; 2001 Apr; 183(8):1304-5. PubMed ID: 11262218 [No Abstract] [Full Text] [Related]
4. Immunosuppression, timing of human herpesvirus 8 infection, and risk of Kaposi's sarcoma among human immunodeficiency virus type 1-infected persons and transplant recipients. Rezza G J Infect Dis; 2000 Dec; 182(6):1809-10. PubMed ID: 11069261 [No Abstract] [Full Text] [Related]
5. Retrospective, longitudinal analysis of serum human herpesvirus-8 viral DNA load in AIDS-related Kaposi's sarcoma patients before and after diagnosis. Polstra AM; Cornelissen M; Goudsmit J; van der Kuyl AC J Med Virol; 2004 Nov; 74(3):390-6. PubMed ID: 15368522 [TBL] [Abstract][Full Text] [Related]
6. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus. Inoue N; Spira T; Lam L; Corchero JL; Luo W J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267 [TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700 [TBL] [Abstract][Full Text] [Related]
8. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count. de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 and Kaposi's sarcoma. Ensoli B; Cafaro A Eur J Cancer Prev; 1996 Oct; 5(5):410-2. PubMed ID: 8972281 [No Abstract] [Full Text] [Related]
10. Kaposi's sarcoma of the tongue. Andres C; Hofmann H; Ring J J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):99-100. PubMed ID: 19522709 [No Abstract] [Full Text] [Related]
11. Kaposi's sarcoma in HIV-infected women and men in Nigeria. Ibekwe PU; Ogunbiyi OA; Ogun GO; George OA AIDS Patient Care STDS; 2011 Nov; 25(11):635-7. PubMed ID: 21967494 [TBL] [Abstract][Full Text] [Related]
12. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection. Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519 [TBL] [Abstract][Full Text] [Related]
13. Kaposi's sarcoma-associated immune reconstitution following highly active antiretroviral treatment initiation. Chan DJ Int J STD AIDS; 2006 Jan; 17(1):72. PubMed ID: 16409689 [No Abstract] [Full Text] [Related]
14. Treatment of Kaposi's sarcoma. Von Roenn JH; Cianfrocca M Cancer Treat Res; 2001; 104():127-48. PubMed ID: 11191125 [No Abstract] [Full Text] [Related]
15. Persistence of Kaposi sarcoma-associated herpesvirus (KSHV)-infected cells in KSHV/HIV-1-coinfected subjects without KSHV-associated diseases. Campbell TB; Staskus KA; Folkvord J; White IE; Neid J; Zhang XQ; Connick E J Infect Dis; 2005 Feb; 191(3):367-71. PubMed ID: 15633095 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma. Stebbing J; Gazzard B; Flore O; Thomas C; Benlahrech A; Mandalia S; Bower M; Gotch F; Patterson S AIDS; 2003 Sep; 17(13):1998-2000. PubMed ID: 12960839 [TBL] [Abstract][Full Text] [Related]
17. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma. Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468 [TBL] [Abstract][Full Text] [Related]
18. What's new in Kaposi's sarcoma research. Trethewey P STEP Perspect; 1997; 9(3):9-10. PubMed ID: 11364938 [TBL] [Abstract][Full Text] [Related]
19. Stimulation of Kaposi's sarcoma-associated herpesvirus viremia during hematopoietic stem cell mobilization with filgrastim. Neid JM; Schooley RT; Campbell TB Am J Hematol; 2004 Dec; 77(4):410-2. PubMed ID: 15551282 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic response of HIV-1 subtype C in African patients coinfected with either Mycobacterium tuberculosis or human herpesvirus-8. Cassol E; Page T; Mosam A; Friedland G; Jack C; Lalloo U; Kopetka J; Patterson B; Esterhuizen T; Coovadia HM J Infect Dis; 2005 Feb; 191(3):324-32. PubMed ID: 15633090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]